United States

ReCode Therapeutics is a genetic medicines company that uses a next-generation, selective organ targeting (SORT) lipid nanoparticle (LNP) platform to deliver mRNA and gene correction therapeutics to target organs and cells beyond the liver. Their lead programs focus on primary ciliary dyskinesia and cystic fibrosis, and they are expanding their pipeline with therapeutics that use mRNA-mediated replacement and gene correction in target organs with precision targeting of disease-relevant cells.

Google

مدیر محصول

دانشمند داده

ReCode Therapeutics

ReCode Therapeutics مشاغل باز

آیا آماده ارتقای شغلی خود هستید؟ این نقش‌های باز در ReCode Therapeutics را بررسی کنید.